Barclays Maintains Overweight on Cencora, Raises Price Target to $415
Barclays analyst Glen Santangelo maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $350 to $415.
Last updated: 2026-11-19 02:27:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Cencora, Inc. (COR) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NYSE. The stock is currently priced at $348.38, with a market capitalization of $68.11B and a P/E ratio of 25.49. Over the past 52 weeks, its price has ranged from $244.82 to $377.54. This page covers its latest market performance, valuation, price trends and company information.
$68.11B | |
$347.16 | |
$349.80 | |
$344.60 | |
$350.56 | |
737.82K | |
1.28M | |
25.49 | |
$377.54 | |
$244.82 | |
0.70% | |
2026-09-30 |
Cencora, Inc. (COR) last closed at $348.38 as of 2026-11-19 00:31:00, down 0.64% ($2.25) from the previous close of $350.56.
During the latest regular trading session, COR traded between $344.60 and $349.80, with a volume of 737.82K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Cencora, Inc. (COR) moved from $345.76 to $348.38, representing a gain of 0.76% ($2.62).
The stock traded between $336.55 and $363.50 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.26 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 78.0%
COR is currently trading at $348.38, placing it 78.0% of the way from its 52-week low of $244.82 to its 52-week high of $377.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices and global specialty drug logistics (World Courier). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Employees | 51,000 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Cencora, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Nov 13, 2026 |
| Payment Date | Nov 30, 2026 |
| Dividend Per Share | $0.66 |
Latest news related to Cencora, Inc. and COR stock.
Barclays analyst Glen Santangelo maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $350 to $415.
Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $395 to $400.
https://www.ftc.gov/news-events/news/press-releases/2026/11/ftc-sues-block-veterinary-supplies-distributor-covetruss-35-billion-acquisition-rival-mwi
Eligible investors can buy real shares of Cencora, Inc. (COR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to COR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between COR shares and USD.
COR Shares to USD
1.00 COR shares = 348.381 USD
Calculations are estimates based on the latest available price and are for reference only.